Past, present and future perspectives in nonalcoholic fatty liver disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Past, present and future perspectives in nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume 16, Issue 6, Pages 377-386
Publisher
Springer Science and Business Media LLC
Online
2019-04-25
DOI
10.1038/s41575-019-0144-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vibration-controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis
- (2018) Jonathan A. Africa et al. Clinical Gastroenterology and Hepatology
- The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease
- (2018) Puneet Puri et al. Clinics in Liver Disease
- Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
- (2018) Stephen A. Harrison et al. GASTROENTEROLOGY
- Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- (2018) Mohammad Shadab Siddiqui et al. HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Preclinical models of non-alcoholic fatty liver disease
- (2018) Prasanna K. Santhekadur et al. JOURNAL OF HEPATOLOGY
- A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
- (2018) Takuma Tsuchida et al. JOURNAL OF HEPATOLOGY
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016
- (2018) Nikhil Tandon et al. Lancet Global Health
- Improvements in Histologic Features and Diagnosis associated with Improvement in Fibrosis in NASH : Results from the NASH Clinical Research Network Treatment Trials
- (2018) Elizabeth M Brunt et al. HEPATOLOGY
- Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum
- (2017) Yuval A. Patel et al. GASTROENTEROLOGY
- Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
- (2017) Charlie C. Park et al. GASTROENTEROLOGY
- Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus
- (2017) Kenneth Cusi GUT
- The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation
- (2017) Soumik BasuRay et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease
- (2017) Raj Vuppalanchi et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
- (2017) Puneet Puri et al. HEPATOLOGY
- Back to Byzance: Querelles byzantines over NASH and fibrosis
- (2017) Vlad Ratziu JOURNAL OF HEPATOLOGY
- Efficacy and safety of simtuzumab for the treatment of nonalcoholic steatohepatitis with bridging fibrosis or cirrhosis: results of two phase 2b, dose-ranging, randomized, placebo-controlled trials
- (2017) A. Sanyal et al. JOURNAL OF HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
- (2017) Sophie Cazanave et al. Scientific Reports
- Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity — United States, 2005–2014
- (2017) C. Brooke Steele et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
- (2016) Scott Friedman et al. Contemporary Clinical Trials
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Inactivation ofTm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins
- (2016) Eriks Smagris et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
- (2016) Petra Hirsova et al. JOURNAL OF LIPID RESEARCH
- Management of NAFLD: a stage-based approach
- (2016) Mary E. Rinella et al. Nature Reviews Gastroenterology & Hepatology
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
- (2015) Arun J. Sanyal et al. HEPATOLOGY
- Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis
- (2015) Srinivasan Dasarathy et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
- (2015) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
- (2014) Arun J. Sanyal et al. GASTROENTEROLOGY
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2013) Paul Angulo et al. GASTROENTEROLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients
- (2013) Mazen Noureddin et al. HEPATOLOGY
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
- (2013) Robert J. Wong et al. HEPATOLOGY
- Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis
- (2013) Yoon Seok Roh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Noninvasive evaluation of NAFLD
- (2013) Laurent Castera et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD in Asia—as common and important as in the West
- (2013) Geoffrey C. Farrell et al. Nature Reviews Gastroenterology & Hepatology
- Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy
- (2013) Ilkay S. Idilman et al. RADIOLOGY
- The Unfolded Protein Response in Fatty Liver Disease
- (2013) Richard Green et al. SEMINARS IN LIVER DISEASE
- Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
- (2012) Kouichi Miura et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
- (2012) Hae-Ki Min et al. Cell Metabolism
- Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
- (2012) Donna L. White et al. Clinical Gastroenterology and Hepatology
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
- (2012) Kouichi Miura et al. HEPATOLOGY
- Increasing Prevalence of Nonalcoholic Fatty Liver Disease Among United States Adolescents, 1988-1994 to 2007-2010
- (2012) Jean A. Welsh et al. JOURNAL OF PEDIATRICS
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase
- (2011) David A. Brenner et al. HEPATOLOGY RESEARCH
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
- (2011) Mattias Ekstedt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
- (2011) Kouichi Miura et al. Gastroenterology Research and Practice
- Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
- (2011) Elizabeth K. Speliotes et al. PLoS Genetics
- Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C
- (2010) Elena Lima-Cabello et al. CLINICAL SCIENCE
- Population-based risk factors and resource utilization for HCC: US perspective
- (2010) A. Sanyal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Hedgehog-Mediated Epithelial-to-Mesenchymal Transition and Fibrogenic Repair in Nonalcoholic Fatty Liver Disease
- (2009) Wing–Kin Syn et al. GASTROENTEROLOGY
- Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
- (2009) Philippe Mathurin et al. GASTROENTEROLOGY
- HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Luca Valenti et al. GASTROENTEROLOGY
- Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study
- (2009) Christine Carter-Kent et al. HEPATOLOGY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial
- (2009) James E. Everhart et al. HEPATOLOGY
- The plasma lipidomic signature of nonalcoholic steatohepatitis
- (2009) Puneet Puri et al. HEPATOLOGY
- Diet-induced hepatocellular carcinoma in genetically predisposed mice
- (2009) A. E. Hill-Baskin et al. HUMAN MOLECULAR GENETICS
- A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
- (2009) Shaoqing He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease
- (2009) Jue WEI et al. Journal of Digestive Diseases
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
- (2009) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Decreased Liver Fatty Acid Δ-6 and Δ-5 Desaturase Activity in Obese Patients
- (2009) Julia Araya et al. Obesity
- Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network
- (2008) Elizabeth M. Brunt et al. HEPATOLOGY
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
- (2008) Onpan Cheung et al. HEPATOLOGY
- Liver biopsy
- (2008) Don C. Rockey et al. HEPATOLOGY
- Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
- (2008) Satoru Yatsuji et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
- (2007) Puneet Puri et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More